July 2024 in “Influenza and Other Respiratory Viruses” Analyzing both TE and AA together is crucial for understanding post-COVID-19 hair loss.
Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.
April 2024 in “Dermatovenerologiâ, kosmetologiâ” Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.
March 2024 in “International Journal of Cosmetic Science” Dandruff is linked to increased T cells and weakened immune protection in hair follicles.
December 2023 in “PubMed” COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.
November 2022 in “Journal of Investigative Dermatology” Statins may help treat alopecia areata by reducing harmful immune interactions.
December 2020 in “Journal of Drugs in Dermatology” The document concludes that more research is needed to confirm if blood tests for things like iron and vitamin D are helpful for hair loss from Telogen effluvium.
Low-level light therapy, possibly combined with other treatments, may become a leading hair loss treatment, while hirsutism often worsens with age and lacks preventive options.
August 2018 in “Journal of The American Academy of Dermatology” People with telogen effluvium and scalp discomfort might have low vitamin B12 and could benefit from B12 supplements.
Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.
February 2017 in “International Journal of Research in Dermatology” A six-year-old girl unusually had a hair loss condition common in middle-aged women.
April 2016 in “Journal of The American Academy of Dermatology” Different treatments are effective for hair loss conditions, but results vary by individual factors.
December 2015 in “Journal of Psoriasis and Psoriatic Arthritis” A patient experienced long-lasting hair loss after using acitretin for psoriasis.
Skin changes throughout life, from development before birth to aging effects like wrinkles, influenced by both genetics and environment.
November 2014 in “British Journal of Dermatology” Male hair loss is mainly due to thinner hair, not less hair.
January 2014 in “Surgical and Cosmetic Dermatology” Nutritional supplements can significantly reduce hair loss in telogen effluvium after three months.
The document concludes that hair loss in women can be caused by various factors and is managed with specific treatments like medication, therapy, and lifestyle changes.
May 2011 in “British Journal of Dermatology” The 1891 epidemic skin disease was likely caused by arsenic poisoning, possibly from beer or fish.
Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.
January 2010 in “Journal of The American Academy of Dermatology” The document provided instructions for completing a CME exam on diagnosing and managing hair loss.
September 2004 in “PubMed” Hair grows in three stages: growing, transition, and resting.
March 2003 in “CRC Press eBooks” Telogen effluvium is hair loss caused by many hairs stopping growth suddenly, often due to stress or illness, but sometimes it's normal and not due to disease.
A man had temporary hair loss after a spinal cord injury, with some permanent thinning remaining.
April 2021 in “Journal of Cosmetic Dermatology” Stem cell treatment improved hair density in female hair loss patient.
November 2014 in “British Journal of Dermatology” Hair loss is due to thinner hairs, not less hairs; hair diameter indicates balding progression and treatment effectiveness.
75 citations,
June 1999 in “Pediatric Clinics of North America” The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.
33 citations,
August 1973 in “American Heart Journal” Propranolol can cause reversible hair loss.
24 citations,
July 1987 in “Dermatologic Clinics” Systemic diseases can cause hair loss, which is often reversible with treatment.
19 citations,
January 2015 in “Journal of Clinical and Diagnostic Research” The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.
1 citations,
August 2018 in “Journal of The American Academy of Dermatology” Teledermatology could improve skin care access, but its success depends on technology, quality strategies, and payment policies; also, vitamin B12 might help treat a specific hair loss condition.